BCL2L15 and cancer: Alternatively, YY1 could recruit enzymes able in turn to modify the chromatin (es., EZH2, HDAC) and, hence, orchestrate changes in the epigenetic status of the BCL2L15 gene, as it was observed in other cancer and non-cancer models [11,39,40].